Carcinogenesis Advance Access published online on February 2, 2007
Carcinogenesis, doi:10.1093/carcin/bgm010
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate
NYU Cancer Institute, NYU School of Medicine, Manhattan VAMC 18th Floor, Rm. 18003 W, 423 East 23rd Street, New York NY 10010
This paper was previously published in Carcinogenesis 27(10) (21242132) doi:10.1093/carcin/bgl075
The ChIP assay result (Figure 5A), one of the three assays shown in figure 5, used to illustrate the effects of PEITC on the formation of Sp1 nuclear binding complex of our paper, published on Carcinogenesis 27, 2124-2132, 2006 (authors LG Wang, XM Liu and JW Chiao) was performed as collaboration by Drs Kinoshita and Johnson, Mt Sinai School of Medicine, New York, NY. However they are not listed as the authors and were not acknowledged in this paper. Therefore, I would like to sincerely apologize on behalf of all original authors and express appreciation for the important contribution of Drs. Kinoshita and Johnson. We can attest to the fact that the data presented in the paper is accurate and reproducible for the conclusions of the paper.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||